960 related articles for article (PubMed ID: 15563248)
1. Viral prophylaxis in organ transplant patients.
Slifkin M; Doron S; Snydman DR
Drugs; 2004; 64(24):2763-92. PubMed ID: 15563248
[TBL] [Abstract][Full Text] [Related]
2. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Hodson EM; Ladhani M; Webster AC; Strippoli GF; Craig JC
Cochrane Database Syst Rev; 2013 Feb; (2):CD003774. PubMed ID: 23450543
[TBL] [Abstract][Full Text] [Related]
3. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
Tan HH; Goh CL
Am J Clin Dermatol; 2006; 7(1):13-29. PubMed ID: 16489840
[TBL] [Abstract][Full Text] [Related]
4. Prophylaxis against herpesvirus infections in transplant recipients.
Ljungman P
Drugs; 2001; 61(2):187-96. PubMed ID: 11270937
[TBL] [Abstract][Full Text] [Related]
5. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Hodson EM; Barclay PG; Craig JC; Jones C; Kable K; Strippoli GF; Vimalachandra D; Webster AC
Cochrane Database Syst Rev; 2005 Oct; (4):CD003774. PubMed ID: 16235341
[TBL] [Abstract][Full Text] [Related]
6. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
Ormrod D; Scott LJ; Perry CM
Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of low dose famciclovir as herpes simplex virus and varicella zoster virus prophylaxis in cytomegalovirus low-risk solid organ transplant recipients.
Crouch A; Le M; Rogers C; Shao S; Kotton C
Transpl Infect Dis; 2021 Oct; 23(5):e13711. PubMed ID: 34379876
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis of herpesvirus infections in immunocompetent and immunocompromised older patients.
Fillet AM
Drugs Aging; 2002; 19(5):343-54. PubMed ID: 12093321
[TBL] [Abstract][Full Text] [Related]
9. Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.
Wagstaff AJ; Faulds D; Goa KL
Drugs; 1994 Jan; 47(1):153-205. PubMed ID: 7510619
[TBL] [Abstract][Full Text] [Related]
10. New developments in the management of cytomegalovirus infection after solid organ transplantation.
Eid AJ; Razonable RR
Drugs; 2010 May; 70(8):965-81. PubMed ID: 20481654
[TBL] [Abstract][Full Text] [Related]
11. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Hodson EM; Craig JC; Strippoli GF; Webster AC
Cochrane Database Syst Rev; 2008 Apr; (2):CD003774. PubMed ID: 18425894
[TBL] [Abstract][Full Text] [Related]
12. Preventive Strategies Against Cytomegalovirus and Incidence of α-Herpesvirus Infections in Solid Organ Transplant Recipients: A Nationwide Cohort Study.
Martin-Gandul C; Stampf S; Héquet D; Mueller NJ; Cusini A; van Delden C; Khanna N; Boggian K; Hirzel C; Soccal P; Hirsch HH; Pascual M; Meylan P; Manuel O;
Am J Transplant; 2017 Jul; 17(7):1813-1822. PubMed ID: 28039960
[TBL] [Abstract][Full Text] [Related]
13. [Prevention and therapy of herpesvirus infections].
Abb J
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of cytomegalovirus in donors & opportunistic viral infections in liver transplant recipients.
Varghese J; Subramanian S; Reddy MS; Shanmugam N; Balajee G; Srinivasan V; Venkataraman J; Mohamed R
Indian J Med Res; 2017 Apr; 145(4):558-562. PubMed ID: 28862190
[TBL] [Abstract][Full Text] [Related]
15. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
[TBL] [Abstract][Full Text] [Related]
16. Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
Jain A; Orloff M; Kashyap R; Lansing K; Betts R; Mohanka R; Menegus M; Ryan C; Bozorgzadeh A
Transplant Proc; 2005 Sep; 37(7):3182-6. PubMed ID: 16213344
[TBL] [Abstract][Full Text] [Related]
17. Infections caused by herpes viruses other than cytomegalovirus in solid organ transplant recipients.
Carratalà J; Montejo M; Pérez-Romero P
Enferm Infecc Microbiol Clin; 2012 Mar; 30 Suppl 2():63-9. PubMed ID: 22542037
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis against herpes infections in kidney transplant patients with special emphasis on CMV.
Birkeland SA; Andersen HK; Gahrn-Hansen B
Scand J Infect Dis; 1998; 30(3):221-6. PubMed ID: 9790127
[TBL] [Abstract][Full Text] [Related]
19. New antiherpesvirus agents. Their targets and therapeutic potential.
Alrabiah FA; Sacks SL
Drugs; 1996 Jul; 52(1):17-32. PubMed ID: 8799682
[TBL] [Abstract][Full Text] [Related]
20. Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.
McGavin JK; Goa KL
Drugs; 2001; 61(8):1153-83. PubMed ID: 11465876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
